AML Debate: Use Gemtuzumab Ozogamicin in Most AML Patients vs. Use in CBF Patients or Not at All? Pro
Year: 2018
Type: article
Author: Roland B. Walter
Institutions: University of Washington, Fred Hutch Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Leukemia and Lymphoma Society
OpenAlex ID: W2888913382